Yan Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Zhao has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Adam J. Brown
Victorian Heart Hospital and Victorian Heart Institute, Monash University, Clayton, VIC, Australia
3 shared publications - Francis Jonathan Ha
Victorian Heart Hospital and Victorian Heart Institute, Monash University, Clayton, VIC, Australia
3 shared publications - Nitesh Nerlekar
Victorian Heart Institute Victorian Heart Hospital Clayton Victoria Australia
3 shared publications - Emily Kotschet
Victorian Heart Hospital , Clayton, Victoria
1 shared publication - Hui-Chen Han
Victorian Heart Institute and Victorian Heart Hospital, Monash University, Monash Health, Clayton, VIC 3168, Australia
1 shared publication
Latest Publications
- 1 November 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (11)
Role of Lifestyle and Risk Factor Modification Clinics in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Incidence and recurrence of atrial fibrillation (AF) are associated with several lifestyle risk factors. Lifestyle and risk factor modification (LRFM) clinics could have a role in comprehensively addressing AF from a holistic, patient-centered approach to improve clinical outcomes. METHODS: We performed a systematic review and meta-analysis of randomized controlled trials evaluating the role of LRFM clinics compared with usual care in patients with AF. The primary end point was atrial arrhythmia recurrence. Secondary end points were AF and heart failure-related hospitalization, cardiovascular death, stroke or transient ischemic attack, and quality-of-life. RESULTS: Eleven randomized controlled trials with a total of 3364 patients were included (5 randomized controlled trials performed in the context of AF ablation). Mean age was 58 to 73 years, 30% were female, and 18% had persistent AF. Duration of follow-up ranged from 3 to 24 months. LRFM clinics significantly reduced the primary end point of arrhythmia recurrence compared with usual care after catheter ablation (odds ratio, 0.34 [95% CI, 0.23–0.51]; P 2 =0%). LRFM clinics also reduced AF-related hospitalization (odds ratio, 0.70 [95% CI, 0.51–0.98]; P =0.04, I 2 =21%) and improved quality-of-life (mean improvement on Short Form 36 Questionnaire, 8.90 [95% CI, 6.91–10.90]; P P =0.16), cardiovascular deaths ( P =0.79), or stroke/transient ischemic attack ( P =0.83). CONCLUSIONS: In this meta-analysis of randomized controlled trials, LRFM clinics reduced AF recurrence after ablation, reduced AF-related hospitalization, and improved quality of life. This study supports a comprehensive multidisciplinary lifestyle risk modification model of care to improve clinical outcomes in patients with AF.
- 1 November 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (11)
Role of Lifestyle and Risk Factor Modification Clinics in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Incidence and recurrence of atrial fibrillation (AF) are associated with several lifestyle risk factors. Lifestyle and risk factor modification (LRFM) clinics could have a role in comprehensively addressing AF from a holistic, patient-centered approach to improve clinical outcomes. METHODS: We performed a systematic review and meta-analysis of randomized controlled trials evaluating the role of LRFM clinics compared with usual care in patients with AF. The primary end point was atrial arrhythmia recurrence. Secondary end points were AF and heart failure-related hospitalization, cardiovascular death, stroke or transient ischemic attack, and quality-of-life. RESULTS: Eleven randomized controlled trials with a total of 3364 patients were included (5 randomized controlled trials performed in the context of AF ablation). Mean age was 58 to 73 years, 30% were female, and 18% had persistent AF. Duration of follow-up ranged from 3 to 24 months. LRFM clinics significantly reduced the primary end point of arrhythmia recurrence compared with usual care after catheter ablation (odds ratio, 0.34 [95% CI, 0.23–0.51]; P 2 =0%). LRFM clinics also reduced AF-related hospitalization (odds ratio, 0.70 [95% CI, 0.51–0.98]; P =0.04, I 2 =21%) and improved quality-of-life (mean improvement on Short Form 36 Questionnaire, 8.90 [95% CI, 6.91–10.90]; P P =0.16), cardiovascular deaths ( P =0.79), or stroke/transient ischemic attack ( P =0.83). CONCLUSIONS: In this meta-analysis of randomized controlled trials, LRFM clinics reduced AF recurrence after ablation, reduced AF-related hospitalization, and improved quality of life. This study supports a comprehensive multidisciplinary lifestyle risk modification model of care to improve clinical outcomes in patients with AF.
- Open Access
- 20 August 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (8)
Procedural Management of Atrial Fibrillation in Older Patients
Atrial fibrillation (AF) is becoming increasingly prevalent worldwide because of population aging and the widespread availability of continuous rhythm monitoring. While medical therapy remains central to management, several procedural strategies are being considered for older patients, including catheter ablation with pulsed field ablation (PFA), atrioventricular node ablation with conduction system pacing (CSP), leadless pacemaker (LPM) implantation, and percutaneous left atrial appendage occlusion (LAAO). Catheter ablation is an established therapy that reduces AF burden and improves quality of life; however, the role of catheter ablation in older patients has historically been limited by higher complication rates and greater arrhythmia recurrence. The emergence of PFA may expand the role of ablation because of its procedural efficiency and favorable safety profile, although randomized data in older patients remain limited. A pace-and-ablate strategy with CSP offers an alternative for older patients with symptomatic persistent AF or tachy-brady syndrome. Indeed, by engaging the native conduction system, CSP provides more physiological ventricular activation and may reduce the risk of pacing-induced cardiomyopathy. LPMs avoid the lead- and pocket-related complications associated with transvenous pacemakers and may be especially advantageous in frail older patients with multiple comorbidities. LAAO is a potential strategy for stroke prevention that is often proposed for patients unable to tolerate long-term anticoagulation, although randomized data remain conflicting. This narrative review evaluates the current evidence supporting these procedures in older patients with AF.
- 20 August 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (8)
Open AccessProcedural Management of Atrial Fibrillation in Older Patients
Atrial fibrillation (AF) is becoming increasingly prevalent worldwide because of population aging and the widespread availability of continuous rhythm monitoring. While medical therapy remains central to management, several procedural strategies are being considered for older patients, including catheter ablation with pulsed field ablation (PFA), atrioventricular node ablation with conduction system pacing (CSP), leadless pacemaker (LPM) implantation, and percutaneous left atrial appendage occlusion (LAAO). Catheter ablation is an established therapy that reduces AF burden and improves quality of life; however, the role of catheter ablation in older patients has historically been limited by higher complication rates and greater arrhythmia recurrence. The emergence of PFA may expand the role of ablation because of its procedural efficiency and favorable safety profile, although randomized data in older patients remain limited. A pace-and-ablate strategy with CSP offers an alternative for older patients with symptomatic persistent AF or tachy-brady syndrome. Indeed, by engaging the native conduction system, CSP provides more physiological ventricular activation and may reduce the risk of pacing-induced cardiomyopathy. LPMs avoid the lead- and pocket-related complications associated with transvenous pacemakers and may be especially advantageous in frail older patients with multiple comorbidities. LAAO is a potential strategy for stroke prevention that is often proposed for patients unable to tolerate long-term anticoagulation, although randomized data remain conflicting. This narrative review evaluates the current evidence supporting these procedures in older patients with AF.
- Open Access
Role of Lifestyle and Risk Factor Modification Clinics in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Background: Incidence and recurrence of atrial fibrillation (AF) is associated with several lifestyle risk factors. Lifestyle and risk factor modification (LRFM) clinics could have a role in comprehensively addressing AF from a holistic patient-centred approach to improve clinical outcomes. Methods: We performed a systematic review and meta-analysis of randomised controlled trials (RCTs) evaluating the role of LRFM clinics compared with usual care (UC) in patients with AF. The primary endpoint was atrial arrhythmia recurrence. Secondary endpoints were AF and heart failure (HF) related hospitalisation, cardiovascular death, stroke or transient ischaemic attack (TIA), and quality-of-life (QOL). Results: A total of eleven RCTs with a total of 3364 patients were included (five RCTs performed in the context of AF ablation). Mean age was 58–73 years, 30% were female and 18% had persistent AF. Duration of follow-up ranged from 3-24 months. LRFM clinics significantly reduced the primary endpoint of arrhythmia recurrence compared with UC after catheter ablation (OR 0.34, 95% CI 0.23-0.51, p2 =0%). LRFM clinics also reduced AF-related hospitalisation (OR 0.70, 95%CI 0.51–0.98, p=0.04, I 2 =21%) and improved QOL (mean improvement on Short Form 36 Questionnaire 8.90, 95% CI 7.6.91–10.90, p<0.001). There was no difference between LRFM clinics and UC for HF-related hospitalisation (p=0.16), cardiovascular deaths (p=0.79) or stroke/TIA (p=0.83). Conclusion: In this meta-analysis of RCTs, LRFM clinics reduced AF recurrence after ablation, reduced AF-related hospitalisation and improved QOL. This study supports a comprehensive multidisciplinary lifestyle risk modification model of care to improve clinical outcomes in patients with AF.
Open AccessRole of Lifestyle and Risk Factor Modification Clinics in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Background: Incidence and recurrence of atrial fibrillation (AF) is associated with several lifestyle risk factors. Lifestyle and risk factor modification (LRFM) clinics could have a role in comprehensively addressing AF from a holistic patient-centred approach to improve clinical outcomes. Methods: We performed a systematic review and meta-analysis of randomised controlled trials (RCTs) evaluating the role of LRFM clinics compared with usual care (UC) in patients with AF. The primary endpoint was atrial arrhythmia recurrence. Secondary endpoints were AF and heart failure (HF) related hospitalisation, cardiovascular death, stroke or transient ischaemic attack (TIA), and quality-of-life (QOL). Results: A total of eleven RCTs with a total of 3364 patients were included (five RCTs performed in the context of AF ablation). Mean age was 58–73 years, 30% were female and 18% had persistent AF. Duration of follow-up ranged from 3-24 months. LRFM clinics significantly reduced the primary endpoint of arrhythmia recurrence compared with UC after catheter ablation (OR 0.34, 95% CI 0.23-0.51, p2 =0%). LRFM clinics also reduced AF-related hospitalisation (OR 0.70, 95%CI 0.51–0.98, p=0.04, I 2 =21%) and improved QOL (mean improvement on Short Form 36 Questionnaire 8.90, 95% CI 7.6.91–10.90, p<0.001). There was no difference between LRFM clinics and UC for HF-related hospitalisation (p=0.16), cardiovascular deaths (p=0.79) or stroke/TIA (p=0.83). Conclusion: In this meta-analysis of RCTs, LRFM clinics reduced AF recurrence after ablation, reduced AF-related hospitalisation and improved QOL. This study supports a comprehensive multidisciplinary lifestyle risk modification model of care to improve clinical outcomes in patients with AF.